Enzyme linked immunosorbent assay kit for detecting porcine reproductive and respiratory syndrome virus antigen and application of enzyme linked immunosorbent assay kit

By developing an enzyme-linked immunization kit based on specific monoclonal antibodies, the problem of long-term detection of pig breeding and respiratory syndrome viruses in the prior art has been solved, and rapid and accurate antigen detection is achieved to meet the needs of large-scale rapid detection.

CN118962126APending Publication Date: 2024-11-15CHINA ANIMAL HUSBANDRY IND
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410953772.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-16
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The existing methods for detection of pig breeding and respiratory syndrome viruses need to be completed in P2 or P3 laboratories, which takes a long time and cannot meet the needs of large-scale rapid testing.

Method used

Develop an enzyme-linked immune kit that specifically quantitatively detects antigens of pig breeding and respiratory syndrome viruses. Using two specific monoclonal antibodies PRRS-Mc1 and PRRS-Mc2, the binding of enzyme-linked reaction plates and enzyme-labeled antibodies is carried out. Achieve fast and accurate detection.

Benefits of technology

It has achieved antigen detection of pig breeding and respiratory syndrome viruses with high sensitivity and good specificity, which is convenient to operate and can complete the detection of up to 88 samples within 1.5 hours, meeting the needs of large-scale rapid detection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004948034950000121
    Figure BDA0004948034950000121
  • Figure BDA0004948034950000122
    Figure BDA0004948034950000122
  • Figure BDA0004948034950000131
    Figure BDA0004948034950000131
Patent Text Reader

Abstract

The invention discloses an enzyme linked immunosorbent assay kit for specific quantitative detection of a porcine reproductive and respiratory syndrome virus antigen and application of the enzyme linked immunosorbent assay kit. The kit comprises an enzyme-linked reaction plate and an enzyme-labeled antibody, wherein the enzyme-linked reaction plate can be coated with a monoclonal antibody which can be specifically combined with the porcine reproductive and respiratory syndrome virus and is used as a capture antibody. The double-antibody sandwich method enzyme-linked immunosorbent assay quantitative detection kit prepared from the two specific monoclonal antibodies of the porcine reproductive and respiratory syndrome virus has high sensitivity and strong specificity, and can effectively detect the content of the porcine reproductive and respiratory syndrome virus.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of biological detection technology. More specifically, the present invention relates to an enzyme-linked immunosorbent assay kit for specific quantitative detection of porcine reproductive and respiratory syndrome virus antigens, which is suitable for specific, rapid and accurate detection of porcine reproductive and respiratory syndrome virus antigens. Background Art

[0002] Porcine reproductive and respiratory syndrome (PRRS) is also known as "blue ear disease". PRRSV mainly replicates in the alveoli and lymphatic organ macrophages of pigs. It is an infectious disease with reproductive system diseases of breeding sows and respiratory system diseases of infected pigs as the main clinical symptoms. The disease was first discovered in the United States and first introduced to my country in 1996. The disease mainly affects lactating piglets and breeding sows. Infected sows mainly show fever, anorexia, abortion of pregnant sows, premature birth, stillbirth, weak fetuses and mummified fetuses. Piglets mainly show coughing, fever, diarrhea, loss of appetite or loss of appetite, muscle tremors, cyanosis of the skin, and even death. Surviving pigs can carry the virus for a long time and can continuously excrete toxins from the body, and they are the main source of infection together with sick pigs.

[0003] The virus particle is an enveloped, icosahedral, single-stranded positive-strand RNA virus with a total genome length of about 15 kb. There are 9 open reading frames (ORFs), with the replicase gene located at the 5' end and the structural protein gene located at the 3' end. Based on the differences in the genomic nucleotide sequence, it can be divided into the European type represented by Lelystad Virus (LV) and the North American type represented by ATCC VR-2332. The main prevalent strain in my country is the North American type.

[0004] N protein is a nucleocapsid protein encoded by ORF7, with a size of about 14-15kDa. It is a strongly alkaline protein and is the earliest expressed and most abundant protein in the virus, accounting for 20-40% of the total protein. Its bases are highly conserved and have many antibody recognition sites. After polymerization, it forms the icosahedral core of the virus particle. GP5, M and N proteins are structural proteins that are indispensable for the formation of virus particles and viral infectivity. Studies have shown that the above three antigens can be used as markers for PRRSV serological detection.

[0005] At present, the main methods for detecting porcine reproductive and respiratory syndrome virus include virus isolation and identification, neutralization test, immunofluorescence method, RT-PCR nucleic acid detection method and LAMP detection method. Since the above detection methods must be completed in P2 or P3 laboratories, and the above methods also require professional laboratory personnel and equipment to complete, and are time-consuming, they cannot meet the needs of large-scale rapid detection. Therefore, it is necessary to develop a porcine reproductive and respiratory syndrome virus antigen detection method that is convenient to operate, specific, sensitive, accurate and reliable.

[0006] Enzyme-Linked Immunosorbent Assays (ELISA) is the mainstream immunoassay technology in the market and has been widely used in clinical testing. It is fast, convenient and highly sensitive. With the development of monoclonal antibody technology, antigen detection methods for various pathogens have been widely used. Since monoclonal antibodies are antibodies prepared by screening a single epitope on an antigen, they can sensitively and specifically identify porcine reproductive and respiratory syndrome virus antigens, laying the foundation for porcine reproductive and respiratory syndrome virus antigen detection methods based on monoclonal antibody technology. Summary of the invention

[0007] The purpose of the present invention is to provide an enzyme-linked immunosorbent assay kit for specific quantitative detection of porcine reproductive and respiratory syndrome virus antigens. The kit uses enzyme-labeled antibodies made from two monoclonal antibodies PRRS-Mc1 that can specifically bind to porcine reproductive and respiratory syndrome virus antigens as capture antibodies and another monoclonal antibody PRRS-Mc2 that can specifically bind to porcine reproductive and respiratory syndrome virus antigens as detection antibodies, thereby establishing a porcine reproductive and respiratory syndrome virus antigen detection method with good specificity, sensitivity and repeatability, which is used to detect the porcine reproductive and respiratory syndrome virus antigen content in the vaccine production process.

[0008] Based on the above purpose, the enzyme-linked immunosorbent assay kit for specific quantitative detection of porcine reproductive and respiratory syndrome virus antigen of the present invention comprises an enzyme-linked reaction plate coated with a monoclonal antibody PRRS-Mc1 that specifically binds to porcine reproductive and respiratory syndrome virus antigen as a capture antibody and an enzyme-labeled antibody; the enzyme-labeled antibody is an enzyme-labeled antibody made by using another monoclonal antibody PRRS-Mc2 that specifically binds to porcine reproductive and respiratory syndrome virus antigen as a detection antibody. The enzyme-labeled antibody is preferably an antibody labeled with horseradish peroxidase, and the horseradish peroxidase can be cross-linked to the antibody by glutaraldehyde method or periodic acid method.

[0009] The capture antibody (monoclonal antibody PRRS-Mc1 that specifically binds to porcine reproductive and respiratory syndrome virus antigen) is a heavy chain variable region PRRS-Mc1-V Hand light chain variable region PRRS-Mc1-V L ; The PRRS-Mc1-V H and PRRS-Mc1-V L The PRRS-Mc1-V H and the PRRS-Mc1-V L The complementary regions of the cluster-determining regions are composed of CDR1, CDR2 and CDR3;

[0010] The PRRS-Mc1-V H The amino acid sequence of CDR1 is shown in amino acids 31 to 35 of SEQ ID No. 1;

[0011] The PRRS-Mc1-V H The amino acid sequence of CDR2 is shown in amino acids 50 to 66 of SEQ ID No. 1;

[0012] The PRRS-Mc1-V H The amino acid sequence of CDR3 is shown in amino acids 99 to 110 of SEQ ID No. 1;

[0013] The PRRS-Mc1-V L The amino acid sequence of CDR1 is shown in amino acids 24 to 34 of SEQ ID No. 2;

[0014] The PRRS-Mc1-V L The amino acid sequence of CDR2 is shown in amino acids 50 to 56 of SEQ ID No. 2;

[0015] The PRRS-Mc1-V L The amino acid sequence of CDR3 is shown in amino acids 89 to 97 of SEQ ID No. 2;

[0016] Preferably, the PRRS-Mc1-V H The amino acid sequence of PRRS-Mc1-V L The amino acid sequence is shown in positions 1 to 108 of SEQ ID No. 2 in the sequence listing;

[0017] The enzyme-labeled antibody (monoclonal antibody PRRS-Mc2 that specifically binds to porcine reproductive and respiratory syndrome virus antigen) contains a heavy chain variable region PRRS-Mc2-VH and a light chain variable region PRRS-Mc2-VL; both the PRRS-Mc2-VH and the PRRS-Mc2-VL are composed of a determinant complementary region and a framework region; the determinant complementary regions of the PRRS-Mc2-VH and the PRRS-Mc2-VL are composed of CDR1, CDR2 and CDR3;

[0018] The amino acid sequence of CDR1 of the PRRS-Mc2-VH is shown in amino acids 32 to 35 of SEQ ID No. 3;

[0019] The amino acid sequence of CDR2 of the PRRS-Mc2-VH is shown in amino acids 50 to 66 of SEQ ID No. 3;

[0020] The amino acid sequence of CDR3 of the PRRS-Mc2-VH is shown in amino acids 99 to 105 of SEQ ID No. 3;

[0021] The amino acid sequence of CDR1 of the PRRS-Mc2-VL is shown in amino acids 24 to 33 of SEQ ID No. 4;

[0022] The amino acid sequence of CDR2 of the PRRS-Mc2-VL is shown in amino acids 49 to 55 of SEQ ID No. 4;

[0023] The amino acid sequence of CDR3 of the PRRS-Mc2-VL is shown in amino acids 88 to 96 of SEQ ID No. 4;

[0024] Preferably, the amino acid sequence of the PRRS-Mc1-VH is shown in positions 1 to 121 of SEQ ID No. 1 in the sequence listing; the amino acid sequence of the PRRS-Mc1-VL is shown in positions 1 to 108 of SEQ ID No. 2 in the sequence listing.

[0025] Preferably, the amino acid sequence of the PRRS-Mc2-VH is shown in positions 1 to 116 of SEQ ID No. 3 in the sequence listing; the amino acid sequence of the PRRS-Mc2-VL is shown in positions 1 to 107 of SEQ ID No. 4 in the sequence listing.

[0026] The optimal coating preparation method and conditions of the enzyme-linked reaction plate are as follows: the specific monoclonal antibody PRRS-Mc1 of the porcine reproductive and respiratory syndrome virus is diluted with a carbonate solution of pH 9.6 to a coating working solution of 1 to 10 μg / ml, and then added to a 96-well polystyrene enzyme-linked reaction plate, 100 μl / well, and placed at 2 to 8°C for 8 to 12 hours to allow the specific monoclonal antibody PRRS-Mc1 to fully bind to the enzyme-linked reaction plate, and then 300 μl / well of a PBS buffer solution containing 10 mg / ml bovine serum albumin, pH 7.4, is added, and the plate is sealed at 37°C for 2 to 3 hours, and after being dried, the enzyme-linked reaction plate is sealed and stored at 2 to 8°C after it is dried.

[0027] Preferably, the kit also includes an antigen standard, which is porcine reproductive and respiratory syndrome virus antigen, with an antigen content of 4 μg / ml. When used, it is diluted with a sample diluent to 3.1 ng / ml to 200 ng / ml. The measured OD 450nm The values ​​were used to draw the standard curve.

[0028] The kit of the present invention is a double antibody sandwich enzyme-linked immunosorbent assay quantitative detection kit made of porcine reproductive and respiratory syndrome virus-specific monoclonal antibodies, which quantitatively detects the antigen content of porcine reproductive and respiratory syndrome virus in a sample by detecting the signal change generated by the enzyme-catalyzed substrate.

[0029] Furthermore, the kit also includes a sample diluent, a 20-fold concentrated washing solution, a substrate solution A, a substrate solution B, and a stop solution. The enzyme-linked reaction plate is a detachable 96-well ELISA plate. The sample diluent is a 0.01M phosphate buffer containing 5 mg / ml casein and a pH value of 7.4. The 20-fold concentrated washing solution is a 0.01M phosphate buffer containing Tween-20 at a concentration of 0.8% to 1.2% (ml / ml) and a pH value of 7.4. The substrate solution A is a citric acid phosphate buffer containing 0.6 mg / ml urea hydrogen peroxide, and the substrate solution B is a 0.2 mg / ml tetramethylbenzidine solution. When used, the two are mixed in a ratio of 1:1. The stop solution is a 2 mol / L sulfuric acid solution.

[0030] The present invention also claims a monoclonal antibody that can specifically bind to a porcine reproductive and respiratory syndrome virus antigen, and is any one of the following monoclonal antibodies:

[0031] 1) Contains the heavy chain variable region PRRS-Mc1-V H and light chain variable region PRRS-Mc1-V L ; The heavy chain variable region PRRS-Mc1-V H and light chain variable region PRRS-Mc1-V LThe PRRS-Mc1-V H and the PRRS-Mc1-V L The complementary regions of the determinant clusters are composed of CDR1, CDR2 and CDR3; the PRRS-Mc1-V H and the PRRS-Mc1-V L The complementary regions of the determinant clusters are composed of CDR1, CDR2 and CDR3; the PRRS-Mc1-V H The amino acid sequence of CDR1 is shown in amino acids 31 to 35 of SEQ ID No. 1; the PRRS-Mc1-V H The amino acid sequence of CDR2 is shown in amino acids 50 to 66 of SEQ ID No. 1; the PRRS-Mc1-V H The amino acid sequence of CDR3 of PRRS-Mc1-V is shown in amino acids 99 to 110 of SEQ ID No.1; L The amino acid sequence of CDR1 is shown in amino acids 24 to 34 of SEQ ID No. 2; the PRRS-Mc1-V L The amino acid sequence of CDR2 is shown in amino acids 50 to 56 of SEQ ID No. 2; the PRRS-Mc1-V L The amino acid sequence of CDR3 is shown in amino acids 89 to 97 of SEQ ID No.2.

[0032] 2) Containing the heavy chain variable region PRRS-Mc2-V H and light chain variable region PRRS-Mc2-V L ; The heavy chain variable region PRRS-Mc2-V H and light chain variable region PRRS-Mc2-V L The PRRS-Mc2-V H and the PRRS-Mc2-V L The complementary regions of the determinant clusters are composed of CDR1, CDR2 and CDR3; the PRRS-Mc2-V H and the PRRS-Mc2-V L The complementary regions of the determinant clusters are composed of CDR1, CDR2 and CDR3; the PRRS-Mc2-V H The amino acid sequence of CDR1 is shown in amino acids 32 to 35 of SEQ ID No. 3; the PRRS-Mc2-V H The amino acid sequence of CDR2 is shown in amino acids 50 to 66 of SEQ ID No. 3; the PRRS-Mc2-VH The amino acid sequence of CDR3 is shown in amino acids 99 to 105 of SEQ ID No. 3; the PRRS-Mc2-V L The amino acid sequence of CDR1 is shown in amino acids 24 to 33 of SEQ ID No. 4; the PRRS-Mc2-V L The amino acid sequence of CDR2 is shown in amino acids 49 to 55 of SEQ ID No. 4; the PRRS-Mc2-V L The amino acid sequence of CDR3 is shown in amino acids 88 to 96 of SEQ ID No.4.

[0033] 3) Containing the heavy chain variable region PRRS-Mc1-V H and light chain variable region PRRS-Mc1-V L ; The PRRS-Mc1-V H The amino acid sequence of PRRS-Mc1-V L The amino acid sequence is shown in positions 1 to 108 of SEQ ID No. 2 in the sequence listing.

[0034] 4) Containing the heavy chain variable region PRRS-Mc2-V H and light chain variable region PRRS-Mc2-V L ; The PRRS-Mc2-V H The amino acid sequence of PRRS-Mc2-V is shown in the 1st to 116th positions of SEQ ID No.3 in the sequence list; L The amino acid sequence is shown in positions 1 to 107 of SEQ ID No. 4 in the sequence listing.

[0035] The above-mentioned heavy chain variable region and light chain variable region sequences can be connected to animal-derived constant regions (such as mouse antibody heavy chain and light chain constant regions) to prepare monoclonal antibodies that can specifically bind to porcine reproductive and respiratory syndrome virus.

[0036] The application of the monoclonal antibody that can specifically bind to porcine reproductive and respiratory syndrome virus antigen in the preparation of a kit for detecting porcine reproductive and respiratory syndrome virus is also within the protection scope of the present invention, especially in the preparation of a kit for detecting porcine reproductive and respiratory syndrome virus.

[0037] The method for obtaining the above-mentioned monoclonal antibody that can specifically bind to the porcine reproductive and respiratory syndrome virus antigen is as follows: screen the porcine reproductive and respiratory syndrome virus-specific monoclonal cell strain of the present invention according to conventional methods known in the art, then use gene sequencing methods to determine the gene sequence of the specific monoclonal cell strain, and use gene synthesis and a method of constructing a recombinant expression vector to prepare a stably expressed monoclonal antibody as the capture monoclonal antibody and the detection monoclonal antibody of the present invention. Specifically, the specific monoclonal antibody of the porcine reproductive and respiratory syndrome virus of the present invention may include the following steps:

[0038] 1) Purify the porcine reproductive and respiratory syndrome live vaccine (R98 strain) antigen (provided by Chengdu Plant of China Animal Husbandry Industry Co., Ltd.) by sucrose density gradient centrifugation method, with a purity of not less than 80%, and adjust the antigen concentration to 1 mg / ml for use as an immunogen;

[0039] 2) Use purified porcine reproductive and respiratory syndrome virus as the immunogen to immunize animals for 4 consecutive times, with an interval of 14 days between each immunization. The first immunization is emulsified with an equal volume of Freund's complete adjuvant, and the subsequent immunizations are emulsified with incomplete Freund's adjuvant. The first 3 immunizations are performed by multi-point subcutaneous immunization, 100 μg / animal, and the fourth immunization is performed by intraperitoneal injection, 200 μg / animal;

[0040] 3) Isolate spleen cells of the immunized animal, fuse them with myeloma cells, screen hybridoma cells with HAT selective culture medium, and screen the hybridoma cell supernatant with indirect ELISA method for specific positive clones; when the serum antibody level of the immunized animal detected by indirect ELISA titer exceeds 1:50000, the spleen cells of the animal can be separated and prepared into a single cell suspension, and fused with myeloma cells (preferably mouse myeloma cells SP2 / 0) under the induction of an appropriate fusion agent (such as polyethylene glycol) to form a hybridoma, and then cultured in HAT culture medium to screen the fused hybridoma cells, and further use indirect ELISA and other methods to identify the desired specific monoclonal antibody cell strains, and after pairing tests, the monoclonal cell strains secreting PRRS-Mc1 and the monoclonal cell strains of PRRS-Mc2 are preferably used as the monoclonal cell strains for detecting porcine reproductive and respiratory syndrome virus antigens.

[0041] 4) Extraction of total RNA from specific positive cloned hybridoma cell lines: Take 250μl of hybridoma cell suspension, add 750μl of Trizol, mix by inversion, add 200μl of chloroform, mix, centrifuge at 4℃12000rpm for 15min. Pipette the supernatant into a new 1.5ml EP tube, add 600μl of isopropanol, mix, centrifuge for 10min. Discard the isopropanol, wash with 75% DEPC ethanol, and centrifuge. Discard the ethanol, dry, and dissolve the RNA with 20μl of RNase-free water.

[0042] 5) Reverse transcription: Use Invitrogen reverse transcription test strips to perform reverse transcription according to the instructions to obtain cDNA of hybridoma cells.

[0043] 6) Variable region sequence determination: The above cDNA was sent to Nanjing GenScript Biotechnology Co., Ltd. for variable region sequence determination and subclass identification to obtain the variable region sequence information of the heavy chain and light chain of the monoclonal antibody.

[0044] 7) Synthesis of gene sequences of specific monoclonal antibodies, construction of shuttle vectors, screening and extraction of recombinant Bacmid, and rescue of recombinant baculovirus: ① Synthesis of gene sequences: Based on the sequences of the heavy and light chain variable regions of the monoclonal antibody PRRS-Mc1, the sequences of the heavy and light chain constant regions of the mouse antibody were added to the variable region, and then sent to Beijing Sino-US Taihe Company for gene sequence synthesis and insect cell codon optimization. ② Construction of shuttle vectors: Based on the sequence information of the heavy and light chains and the sequence information of the pFastBacdual vector, the corresponding primers were designed to amplify the full-length fragments of the heavy and light chains. After gel recovery, the fragments were connected to the pFastBacdual vector by homologous recombination. The pFastBacdual vector contains two promoters, namely the PH promoter and the P10 promoter. After being connected to the vector, sequence determination was performed to ensure the accuracy of the sequence. ③ Screening and extraction of recombinant Bacmid: The constructed shuttle vector was transformed into DH10Bac competent cells, and then coated with triple-antibody plates (kanamycin, gentamicin, and tetracycline). After 48 hours of incubation at 37°C, white spots were picked for identification. The target fragment size of the positive clone was 4600bp, and the negative clone was 300bp. The clones with no 300bp band were selected for shaking. After 12 hours, the Bacmid was extracted by isopropanol precipitation method, and then the concentration was measured by Nanodrop. ④ Rescue of recombinant baculovirus: Before transfection, the density of 2×10 6 SF9 cells were plated in six-well plates, and recombinant Bacmid was transfected at 5μg and 2.5μg. The transfection reagent was 8μl. The medium was changed 4-6h after transfection, and cultured at 28℃. After 72h, the P2 generation virus was harvested and amplified, and the P3 generation virus was amplified in the same way. The P4 generation virus was amplified by shaking flask amplification, and the virus inoculation ratio was 1:100.

[0045] 8) Expression and purification of specific monoclonal antibodies: The P4 virus was inoculated at a density of 2×10 6Hi5 cells were cultured at 28°C, and the cells were harvested after 48 hours. The supernatant was centrifuged at 8000r / min for 1 hour, and then filtered with a 0.22μm filter membrane for later use. The ProteinA pre-packed column was balanced with a Na3PO4 solution with a pH value of 7.0 for 3 to 5 column volumes, and then the cell supernatant was combined with the ProteinA pre-packed column. After the sample was combined, it was eluted with a Glycine-HCL eluent with a pH value of 3.0 to obtain purified porcine reproductive and respiratory syndrome virus PRRS-Mc1 and PRRS-Mc2.

[0046] The detection procedure of the kit of the present invention is:

[0047] 1) Balance: Take the test kit out of the refrigerated environment and equilibrate it at room temperature for 30 minutes before use; mix the liquid reagents before use.

[0048] 2) Preparation of solution: dilute the concentrated washing solution 20 times with distilled water or deionized water to obtain washing buffer solution;

[0049] 3) Sample dilution: The antigen standard (antigen content is 4 μg / ml) is diluted in a series of 1:20 to 1:1280 times with sample diluent, and the corresponding antigen concentrations are 200 ng / ml, 100 ng / ml, 50 ng / ml, 25 ng / ml, 12.5 ng / ml, 6.2 ng / ml, and 3.1 ng / ml. The samples to be tested are also diluted 4 to 8 times with sample diluent.

[0050] 4) Sample addition: Take out the required strips, put the remaining strips into an aluminum foil bag, seal it, and store it at 2-8°C for later use. Add the diluted sample to be tested and the serially diluted antigen standard to the coated plate, 100μl / well, set one well as a negative control, and only add the sample diluent. The time span of the sample addition process should be as short as possible. Figure 1 Sample addition as shown: S1~S7: 1:20~1:1280 times dilution of antigen standard, N: indicates negative quality control well, only sample diluent is added; T1: indicates adding each sample to be tested.

[0051] 5) Incubation: Mix by shaking, place in a 37°C incubator, and react for 30 minutes.

[0052] 6) Washing: discard the reaction solution, add 300 μl of diluted washing buffer to each well, soak for 15 seconds, discard the washing solution, wash the plate 4 times in a row and pat dry.

[0053] 7) Add enzyme: Add 100 μl of enzyme-labeled antibody to each well.

[0054] 8) Incubation: Place in a 37°C incubator and react for 30 minutes.

[0055] 9) Washing: discard the reaction solution, add 300 μl of diluted washing buffer to each well, soak for 15 seconds, discard the washing solution, wash the plate 4 times in a row and pat dry.

[0056] 10) Color development: Add 100 μl of substrate working solution to each well (substrate working solution is prepared by mixing equal amounts of substrate solution A and substrate solution B, and is prepared immediately before use), shake to mix, and place in a 37°C incubator in the dark for 15 minutes.

[0057] 11) Add 50 μl of color stop solution to each well and shake to stop the reaction.

[0058] 12) Determine the OD450nm value of each well (the OD450nm value of the reaction plate with the stop solution should be read within 15 minutes).

[0059] 13) Result analysis: Antigen standard S1 well OD 450nm The value should be ≥1.5, and the OD of the negative control well 450nm The value should be ≤0.15, otherwise it is invalid; S / N value ≥2.1, it is judged as positive; S / N value <2.1, it is judged as negative. Concentration calculation: according to the OD of each well of the antigen standard 450n The standard curve was drawn based on the m value, and the content of porcine reproductive and respiratory syndrome virus in each sample was calculated.

[0060] In the above detection method, the selection of samples to be tested can be diverse, and can be biopsies from infected animals, or porcine reproductive and respiratory syndrome antigens in the vaccine production process, etc.

[0061] The result analysis method in step 13) can be: using the OD of each dilution of the antigen standard test well 450nm OD value and negative control well 450nm Use the value as the X-axis and the protein concentration as the Y-axis in the EXCEL program, → "Insert" → "Scatter plot", select "Scatter plot with smooth line and data markers" → "Trend line" → select "Polynomial" → "Show formula" and "Show R square value". Usually, R2 value ≥ 0.98 indicates that the standard curve is credible (points with OD too high or too low should be discarded). Each 96-well plate should have a set of standards and draw the corresponding standard curve. According to the polynomial formula, the OD of the sample wells 450nm The value was used to calculate the antigen concentration in the sample.

[0062] The positive effect of the present invention is that the present invention provides an enzyme-linked immunosorbent assay kit for quantitative detection of porcine reproductive and respiratory syndrome virus, which has high sensitivity, good specificity, and convenient operation, and can stably detect the content of porcine reproductive and respiratory syndrome virus antigen. The kit is a double antibody sandwich enzyme-linked immunosorbent assay quantitative detection kit made of two specific monoclonal antibodies of porcine reproductive and respiratory syndrome virus, which can quantitatively detect the content of porcine reproductive and respiratory syndrome virus antigen in a sample by detecting the signal change generated by the enzyme-catalyzed substrate, and has no cross reaction with other viruses such as porcine circovirus type 2, foot-and-mouth disease virus type O, foot-and-mouth disease virus type A, and classical swine fever virus.

[0063] In summary, this kit uses a double antibody sandwich enzyme-linked immunosorbent assay quantitative detection kit made of two specific monoclonal antibodies of porcine reproductive and respiratory syndrome virus, which has high sensitivity and strong specificity, and can effectively detect the content of porcine reproductive and respiratory syndrome virus antigen in samples. At the same time, this operation method can complete the detection of up to 88 samples except antigen standards and negative quality control wells within 1.5 hours, greatly shortening the detection cycle, providing a more convenient and effective method for the identification of porcine reproductive and respiratory syndrome virus infection and quality control in vaccine production, and has broad market prospects and good economic and social benefits. BRIEF DESCRIPTION OF THE DRAWINGS

[0064] Figure 1 This is a schematic diagram of loading samples on the enzyme-linked immunosorbent assay plate of the kit of the present invention. DETAILED DESCRIPTION

[0065] The methods in the following embodiments are conventional methods unless otherwise specified.

[0066] The methods for obtaining various biological materials described in the examples are only provided as an experimental method to achieve the specific disclosed purpose, and should not be construed as limiting the sources of the biological materials of the present invention. In fact, the sources of the biological materials used are extensive, and any biological materials that are obtainable without violating laws and ethics can be replaced and used according to the instructions in the examples.

[0067] The embodiments are implemented on the premise of the technical solution of the present invention, and detailed implementation methods and specific operation processes are given. The embodiments will help to understand the present invention, but the protection scope of the present invention is not limited to the following embodiments.

[0068] Example 1. Screening of specific hybridoma cell lines of porcine reproductive and respiratory syndrome virus monoclonal antibodies

[0069] The following steps are involved:

[0070] 1) Purify the porcine reproductive and respiratory syndrome live vaccine (R98 strain) antigen (provided by Chengdu Plant of China Animal Husbandry Industry Co., Ltd.) by sucrose density gradient centrifugation method, with a purity of not less than 80%, and adjust the antigen concentration to 1 mg / ml for use as an immunogen;

[0071] 2) Purified porcine reproductive and respiratory syndrome virus was used as the immunogen in BALB / c mice (purchased from Beijing Weitonglihua Experimental Animal Technology Co., Ltd.) and immunized 4 times in succession, with an interval of 14 days between each immunization. The first immunization was emulsified with an equal volume of Freund's complete adjuvant, and the subsequent immunizations were immunized with incomplete Freund's adjuvant. The first 3 immunizations were performed by multi-point subcutaneous immunization, 100 μg / mouse, and the fourth immunization was performed by intraperitoneal injection, 200 μg / animal;

[0072] 3) 7 days after the last immunization, the tail blood of the mice was collected to separate the serum, which was tested by indirect ELISA. When the titer was greater than 1:50,000, the spleen cells of the immunized animals were separated and fused with myeloma cells SP2 / 0 in good growth state, and hybridoma cells were obtained by screening with HAT selective medium;

[0073] 4) The hybridoma cell supernatant was screened for specific positive clones by the indirect ELISA method, and finally 3 specific positive clones were obtained; the specific operation steps were as follows: the porcine reproductive and respiratory syndrome virus inactivated antigen was dissolved in a carbonate solution with a pH of 9.6 and diluted to a concentration of 2 μg / ml, and then added to a 96-well polystyrene enzyme-linked reaction plate, 100 μl per well, and placed at 2-8°C for 8-12 hours to allow the specific monoclonal antibody to fully bind to the enzyme-linked reaction plate, and then 300 μl / well was added with a PBS buffer containing 10 mg / ml bovine serum albumin at pH 7.4, and the plate was blocked at 37°C for 2-3 hours, and after drying, the enzyme-linked reaction plate was sealed with aluminum foil after drying, and stored at 2-8°C for later use.

[0074] Take the cell culture supernatant and add it to the ELISA plate coated with the virus antigen, react at 37°C for 30 minutes, wash the plate 4 times with washing solution (0.01M phosphate buffer with pH 7.4 containing 0.8% to 1.2% (ml / ml) Tween-20, dilute 20 times with double distilled water when used.), and pat dry. Add 1:5000 diluted rabbit anti-mouse IgG-HRP marker (purchased from Sigma, USA) to each well, react at 37°C for 30 minutes, wash it 4 times, pat dry, and add 50μl substrate working solution of substrate solution A (citric acid phosphate buffer containing 0.6mg / ml hydrogen peroxide urea) and substrate solution B (0.2mg / ml tetramethylbenzidine solution) to each well, and react at 37°C in the dark for 15 minutes. Add 50μl stop solution (2mol / L sulfuric acid solution) to each well, and shake and mix to terminate the reaction. Measure the OD of each well within 15 minutes 450nmThe absorbance value > negative control (i.e., plate washing medium) × 2.1 times was used as the positive judgment standard to determine the titer of specific monoclonal antibodies in the cell culture supernatant, and at the same time, to determine whether the monoclonal antibody cell lines had cross reactions with other viruses, such as porcine circovirus type 2, foot-and-mouth disease virus type O, foot-and-mouth disease virus type A, and classical swine fever virus. Finally, two specific cell clones were obtained, which only had strong signal reactions with porcine reproductive and respiratory syndrome virus, but did not react with negative control, porcine circovirus type 2, foot-and-mouth disease virus type O, foot-and-mouth disease virus type A, and classical swine fever virus. These two monoclonal antibodies were numbered PRRS-Mc1 and PRRS-Mc2, respectively.

[0075] Example 2: Pairing test of purified monoclonal antibodies against porcine reproductive and respiratory syndrome virus

[0076] 1) Preparation of coated plates with porcine reproductive and respiratory syndrome virus specific monoclonal antibodies

[0077] The purified specific monoclonal antibody was diluted with a carbonate solution at pH 9.6 to 0.5 μg / ml, 1 μg / ml, 2 μg / ml, and 4 μg / ml coating working solution, and then added to a 96-well polystyrene enzyme-linked reaction plate at 100 μl / well, and placed at 2-8°C for 8-12 hours to allow the specific monoclonal antibody to fully bind to the enzyme-linked reaction plate, and then 300 μl / well of PBS buffer containing 10 mg / ml bovine serum albumin at pH 7.4 was added, and the plate was blocked at 37°C for 2-3 hours. After drying, the enzyme-linked reaction plate was sealed and stored at 2-8°C after it was dried.

[0078] 2) Preparation of horseradish peroxidase-labeled porcine reproductive and respiratory syndrome virus-specific monoclonal antibody

[0079] The specific monoclonal antibody of porcine reproductive and respiratory syndrome virus was coupled with horseradish peroxidase (HRP) by glutaraldehyde oxidation method, fully dialyzed with pH 7.4 PBS buffer, added with an equal amount of high-quality glycerol, and stored below -20°C. The specific steps are as follows:

[0080] ① Dissolve 5 mg HRP in 0.2 ml PBS buffer (pH 6.8) containing 1.25% glutaraldehyde, and allow to couple at room temperature for 18 hours to fully dialyze away excess glutaraldehyde.

[0081] ② Add physiological saline to 1 ml, then add 2.5 mg of purified porcine reproductive and respiratory syndrome virus specific monoclonal antibody and 0.1 ml of 1 mol / L carbonate buffer with a pH value of 9.6, and place at 2-8°C for 24 hours;

[0082] ③ Add 0.1 ml of 0.3 mol / L lysine solution and leave at room temperature for 2 hours;

[0083] ④ Fully dialyze with pH 7.4 PBS buffer, remove the precipitate by centrifugation, and the supernatant is the enzyme conjugate. Dilute it with enzyme marker diluent at a certain ratio (1:2000, 1:4000 and 1:6000 dilution) to obtain the enzyme marker working solution.

[0084] 3) The pairing test between two specific antibodies was determined using the checkerboard titration method.

[0085] ① Add antigen: dilute the antigen with sample diluent, one concentration is 100ng / ml, the other concentration is 10ng / ml, 100μl / well, react at 37℃ for 30 minutes;

[0086] ② Add enzyme-labeled monoclonal antibody: After washing the plate 4 times, add enzyme-labeled monoclonal antibody and react at 37℃ for 30 minutes;

[0087] ③ Color development: After washing the plate 4 times, add 100 μl of substrate working solution (substrate working solution is prepared by mixing equal amounts of substrate solution A and substrate solution B, which should be prepared immediately before use), shake and mix, place in a 37°C incubator, and react for 15 minutes in the dark;

[0088] ④ Reading: Add 50 μl of color stop solution to each well, shake and mix to stop the reaction. Measure the OD of each well. 450nm Value. Use the OD of 100 ng / ml sample 450nm The value (A) was divided by the OD of the 10 ng / ml sample. 450nm The larger the A / B value, the higher the detection sensitivity of the paired monoclonal antibody. The results are shown in Tables 1 and 2. Therefore, PRRS-Mc1 is preferably used as both the capture antibody and the detection antibody for detection. PRRS-Mc1 can be selected as 1 μg / ml as the capture antibody, and PRRS-Mc2 can be selected as 1:4000 dilution as the detection antibody.

[0089] Table 1 Pairing test results using PRRS-Mc1 as capture antibody (A / B value)

[0090]

[0091] Table 2 Pairing test results using PRRS-Mc2 as capture antibody (A / B value)

[0092]

[0093]

[0094] Example 3. Gene sequencing of porcine reproductive and respiratory syndrome virus-specific hybridoma cell line, establishment of monoclonal antibody recombinant expression system and purification of monoclonal antibodies

[0095] The following steps are involved:

[0096] 1) Total RNA extraction, reverse transcription, PCR and sequence determination of specific positive clone hybridoma cell lines:

[0097] ①Total RNA extraction: Take 250μl of hybridoma cell suspension, add 750μl of Trizol, mix by inversion, add 200μl of chloroform, mix, centrifuge at 4℃12000rpm for 15min. Pipette the supernatant into a new 1.5ml EP tube, add 600μl of isopropanol, mix, centrifuge for 10min. Discard the isopropanol, wash with 75% DEPC ethanol, and centrifuge. Discard the ethanol, dry, and dissolve the RNA with 20μl of RNase-free water.

[0098] ② Reverse transcription: Use the Invitrogen reverse transcription kit according to the instructions to perform reverse transcription to obtain the cDNA of hybridoma cells.

[0099] ③ Variable region sequence determination: The above cDNA was sent to Nanjing GenScript Biotechnology Co., Ltd. for variable region sequence determination and subclass identification to obtain the variable region sequence information of the heavy chain and light chain of the monoclonal antibody.

[0100] The monoclonal antibody PRRS-Mc1 contains a heavy chain variable region (PRRS-Mc1-VH) and a light chain variable region (PRRS-Mc1-VL). The amino acid sequence of PRRS-Mc1-VH is shown in positions 1 to 121 of SEQ ID No. 1 in the sequence listing; the amino acid sequence of PRRS-Mc1-VL is shown in positions 1 to 108 of SEQ ID No. 2 in the sequence listing.

[0101] The PRRS-Mc1-VH and PRRS-Mc1-VL are both composed of a determinant complementary region and a framework region; the determinant complementary regions of the PRRS-Mc1-VH and the PRRS-Mc1-VL are both composed of CDR1, CDR2 and CDR3; the amino acid sequence of CDR1 of the PRRS-Mc1-VH is shown in the 31st to 35th amino acids of SEQ ID No.1; the amino acid sequence of CDR2 of the PRRS-Mc1-VH is shown in the 50th to 66th amino acids of SEQ ID No.1; the amino acid sequence of CDR3 of the PRRS-Mc1-VH is shown in the 99th to 110th amino acids of SEQ ID No.1; the amino acid sequence of CDR1 of the PRRS-Mc1-VL is shown in the 24th to 34th amino acids of SEQ ID No.2; the amino acid sequence of CDR2 of the PRRS-Mc1-VL is shown in SEQ ID The amino acid sequence of the CDR3 of PRRS-Mc1-VL is shown as the amino acids at positions 89 to 97 of SEQ ID No.2.

[0102] The monoclonal antibody PRRS-Mc2 contains a heavy chain variable region (PRRS-Mc2-VH) and a light chain variable region (PRRS-Mc2-VL). The amino acid sequence of PRRS-Mc2-VH is shown in positions 1 to 116 of SEQ ID No. 3 in the sequence listing; the amino acid sequence of PRRS-Mc2-VL is shown in positions 1 to 107 of SEQ ID No. 4 in the sequence listing.

[0103] The PRRS-Mc2-VH and PRRS-Mc2-VL are both composed of a determinant complementary region and a framework region; the determinant complementary regions of the PRRS-Mc2-VH and the PRRS-Mc2-VL are both composed of CDR1, CDR2 and CDR3; the amino acid sequence of CDR1 of the PRRS-Mc2-VH is shown in the 32nd to 35th amino acids of SEQ ID No.3; the amino acid sequence of CDR2 of the PRRS-Mc2-VH is shown in the 50th to 66th amino acids of SEQ ID No.3; the amino acid sequence of CDR3 of the PRRS-Mc2-VH is shown in the 99th to 105th amino acids of SEQ ID No.3; the amino acid sequence of CDR1 of the PRRS-Mc2-VL is shown in the 24th to 33rd amino acids of SEQ ID No.4; the amino acid sequence of CDR2 of the PRRS-Mc2-VL is shown in SEQ ID The amino acid sequence of the CDR3 of PRRS-Mc2-VL is shown as the amino acids 49 to 55 of SEQ ID No.4; the amino acid sequence of the CDR3 of PRRS-Mc2-VL is shown as the amino acids 88 to 96 of SEQ ID No.4.

[0104] 2) Synthesis of specific monoclonal antibody gene sequences and establishment of recombinant expression system

[0105] ① Synthesis of gene sequences: Based on the sequences of the heavy chain and light chain variable regions of the monoclonal antibodies PRRS-Mc1 and PRRS-Mc2, the sequences of the heavy chain and light chain constant regions of the mouse antibody were supplemented in the variable region, and then the gene sequences were synthesized and insect cell codons were optimized. The nucleotide sequence of the PRRS-Mc1 heavy chain is shown in SEQ ID No. 5 (the full-length sequence is the coding sequence) in the sequence listing, and the nucleotide sequence of the PRRS-Mc1 light chain is shown in SEQ ID No. 6 (the full-length sequence is the coding sequence) in the sequence listing;

[0106] The nucleotide sequence of the PRRS-Mc2 heavy chain is shown in SEQ ID No.7 (the full-length sequence is the coding sequence) in the sequence listing, and the nucleotide sequence of the PRRS-Mc2 light chain is shown in SEQ ID No.8 (the full-length sequence is the coding sequence) in the sequence listing;

[0107] ② Construction of shuttle vector: According to the sequence information of heavy chain and light chain and the sequence information of pFastBacdual (purchased from ThermoFisher, catalog number 10712024) vector, the corresponding primers were designed (sequences are shown in Table 3 below), and the full-length fragments of heavy chain and light chain were amplified. After gel recovery, they were connected to the pFastBacdual vector by homologous recombination. The pFastBacdual vector contains two promoters, namely the PH promoter and the P10 promoter, and the GP67 signal peptide sequence information is contained behind the PH promoter sequence, and the HDM signal peptide sequence information is contained behind the P10 promoter sequence. After being connected to the vector, sequence determination was performed to ensure the accuracy of the sequence.

[0108] Table 3 Primer sequence information for expression vector construction

[0109] Name Sequence (5’-3’) PRRS-Mc1-HF TCATACATCTACGCGGCCGCTAGCGAGGTGCAATTGCAGC PRRS-Mc1-HR TCCCCCATCTCCCGGTACCACTAGATACTGTCACA PRRS-Mc1-LF CTGCCTTTGCGGCGGATGAATTC GATATACAAATGACGC PRRS-Mc1-LR CTAGTACTTCTCGACAAGCTTCCGCTTAATTTCTAGT PRRS-Mc2-HF TCATACATCTACGCGGCCGCTAGCGAGGTTCAACTTCAGC PRRS-Mc2-HR TCCCCCATCTCCCGGTACCGCTTGAAACGGTTACA PRRS-Mc24-LF CTGCCTTTGCGGCGGATGAATTCGACATCGTTATGACTCACTC PRRS-Mc2-LR CTAGTACTTCTCGACAAGCTTTCTCTTAATTTCTAAT

[0110] ③ Screening and extraction of recombinant Bacmid: The constructed shuttle vector was transformed into DH10Bac competent medium, and then coated with triple-antibody plates (kanamycin, gentamicin, and tetracycline). After culturing in a 37°C incubator for 48 hours, white spots were picked out and identified using M13 primers. The target fragment size of the positive clone was 4600bp, and that of the negative clone was 300bp. The clones with no 300bp band were selected and shaken. After 12 hours, the Bacmid was extracted using the isopropanol precipitation method, and the concentration was measured using Nanodrop.

[0111] ④ Rescue of recombinant baculovirus: Before transfection, the density of 6SF9 cells were plated in six-well plates, and recombinant Bacmid was transfected at 5μg and 2.5μg. The transfection reagent was 8μl. The medium was changed 4-6h after transfection, and cultured at 28℃. After 72h, the P2 generation virus was harvested and amplified, and the P3 generation virus was amplified in the same way. The P4 generation virus was amplified by shaking flask amplification, and the virus inoculation ratio was 1:100.

[0112] 3) Expression and purification of specific monoclonal antibodies: The P4 virus was inoculated at a density of 2×10 6 Hi5 cells were cultured at 28°C, and the cells were harvested after 48 hours. The supernatant was centrifuged at 8000r / min for 1 hour, and then filtered with a 0.22μm filter membrane for later use. The ProteinA pre-packed column was equilibrated with a Na3PO4 solution with a pH value of 7.0 for 3 to 5 column volumes, and then the cell supernatant was combined with the ProteinA pre-packed column. After the sample was combined, it was eluted with a Glycine-HCL eluent with a pH value of 3.0 to obtain purified porcine reproductive and respiratory syndrome virus-specific monoclonal antibodies PRRS-Mc1 and PRRS-Mc2. The OD was measured with a UV spectrophotometer. 280nm value, use this OD 280nm The value divided by the empirical coefficient 1.48 is the concentration of the monoclonal antibody, in mg / ml. The results showed that the concentration of the monoclonal antibody secreted by PRRS-Mc1 was 1.86 mg / ml, and the concentration of the monoclonal antibody secreted by PRRS-Mc2 was 1.97 mg / ml.

[0113] Example 4: Preparation of ELISA kit for quantitative detection of porcine reproductive and respiratory syndrome virus antigen

[0114] 1) Preparation of antigen-coated plates using porcine reproductive and respiratory syndrome virus-specific monoclonal antibodies

[0115] The purified specific monoclonal antibody was diluted with a carbonate solution at pH 9.6 to a coating working solution of 1 μg / ml, and then added to a 96-well polystyrene ELISA plate at 100 μl / well and placed at 2-8°C for 8-12 hours to allow the specific monoclonal antibody to fully bind to the ELISA plate. Then, 300 μl / well of PBS buffer containing 10 mg / ml bovine serum albumin at pH 7.4 was added, and the plate was blocked at 37°C for 2-3 hours. After drying, the ELISA plate was sealed and stored at 2-8°C after drying.

[0116] 2) Preparation of horseradish peroxidase-labeled porcine reproductive and respiratory syndrome virus-specific monoclonal antibody

[0117] The porcine reproductive and respiratory syndrome virus specific monoclonal antibody prepared in Example 3 was coupled with horseradish peroxidase (HRP) by glutaraldehyde oxidation method, fully dialyzed with pH 7.4 PBS buffer, added with an equal amount of high-quality glycerol, and stored below -20°C. The specific steps are as follows:

[0118] ① Dissolve 5 mg HRP in 0.2 ml PBS buffer (pH 6.8) containing 1.25% glutaraldehyde, and allow to couple at room temperature for 18 hours to fully dialyze away excess glutaraldehyde.

[0119] ② Add physiological saline to 1 ml, then add 2.5 mg of purified porcine reproductive and respiratory syndrome virus-specific monoclonal antibody and 0.1 ml of 1 mol / L carbonate buffer with a pH value of 9.6, and place at 2-8°C for 24 hours;

[0120] ③ Add 0.1 ml of 0.3 mol / L lysine solution and leave at room temperature for 2 hours;

[0121] ④ Fully dialyze with pH 7.4 PBS buffer, remove the precipitate by centrifugation, and the supernatant is the enzyme conjugate. Dilute it with enzyme marker diluent at 1:4000 to obtain the enzyme marker working solution.

[0122] 3) Preparation of porcine reproductive and respiratory syndrome virus antigen standard

[0123] To facilitate result analysis, the kit also includes a porcine reproductive and respiratory syndrome virus antigen standard, which can be a porcine reproductive and respiratory syndrome virus antigen concentrated purified solution with an antigen content of 4ug / ml, which is packaged into 1.0ml / tube. When used, it is diluted with a sample diluent (1:20 to 1:1280), labeled, and stored below -20°C for future use.

[0124] 4) The sample diluent is prepared as 0.01 M phosphate buffer with a pH of 7.4 and containing 5 mg / ml casein, 1 bottle (24 ml / bottle).

[0125] 5) Substrate solution A is prepared by 0.6 mg / ml urea hydrogen peroxide in citrate phosphate buffer (1 bottle, 12 ml / bottle)

[0126] 6) Substrate solution B is prepared as 0.2 mg / ml tetramethylbenzidine (TMB) solution (1 bottle, 12 ml / bottle).

[0127] 7) The preparation of 20-fold concentrated washing solution is 0.01 M phosphate buffer with a pH value of 7.4 and a concentration of 0.8% to 1.2% (ml / ml) of Tween-20 (50 ml / bottle, 2 bottles).

[0128] 8) Preparation of stop solution: 2 mol / L sulfuric acid solution (1 bottle, 12 ml / bottle).

[0129] 9) If necessary, the kit may also include a sample dilution plate (2 plates, 96 wells / plate) for sample dilution.

[0130] Example 5: Method for using the enzyme-linked immunosorbent assay kit for quantitative detection of porcine reproductive and respiratory syndrome virus antigen

[0131] 1) Balance: Take the test kit out of the refrigerated environment and equilibrate it at room temperature for 30 minutes before use; mix the liquid reagents before use.

[0132] 2) Preparation of solution: dilute the concentrated washing solution 20 times with distilled water or deionized water to obtain washing buffer solution;

[0133] 3) Sample dilution: The antigen standard was diluted in a series of 1:20 to 1:1280 times with sample diluent, and the corresponding antigen concentrations were 200ng / ml, 100ng / ml, 50ng / ml, 25ng / ml, 12.5ng / ml, 6.2ng / ml, and 3.1ng / ml. The samples to be tested were also diluted 4 to 8 times with sample diluent.

[0134] 4) Sample addition: Take out the required strips, put the remaining strips into an aluminum foil bag, seal it, and store it at 2-8°C for later use. Add the diluted sample to be tested and the serially diluted antigen standard to the coated plate, 100μl / well, set one well as a negative control, and only add the sample diluent. The time span of the sample addition process should be as short as possible. Figure 1 As shown, sample addition: S1~S7: 1:20~1:1280 times dilution of antigen standard, N: represents negative quality control well, only add sample diluent; T1: represents adding each sample to be tested.

[0135] 5) Incubation: Mix by shaking, place in a 37°C incubator, and react for 30 minutes.

[0136] 6) Washing: discard the reaction solution, add 300 μl of diluted washing buffer to each well, soak for 15 seconds, discard the washing solution, wash the plate 4 times in a row and pat dry.

[0137] 7) Add enzyme: Add 100 μl of enzyme-labeled antibody to each well.

[0138] 8) Incubation: Place in a 37°C incubator and react for 30 minutes.

[0139] 9) Washing: discard the reaction solution, add 300 μl of diluted washing buffer to each well, soak for 15 seconds, discard the washing solution, wash the plate 4 times in a row and pat dry.

[0140] 10) Color development: Add 100 μl of substrate working solution to each well (substrate working solution is prepared by mixing equal amounts of substrate solution A and substrate solution B, and is prepared immediately before use), shake to mix, and place in a 37°C incubator in the dark for 15 minutes.

[0141] 11) Add 50 μl of color stop solution to each well and shake to stop the reaction.

[0142] 12) Measure the OD of each well 450nm Value (OD should be read within 15 minutes after adding the stop solution to the reaction plate 450nm value).

[0143] 13) Result analysis: Antigen standard S1 well OD 450nm The value should be ≥1.5, and the OD of the negative control well 450nm The value should be ≤0.15, otherwise it is invalid; S / N value ≥2.1, it is judged as positive; S / N value <2.1, it is judged as negative. Concentration calculation: according to the OD of each well of the antigen standard 450nm The standard curve was drawn based on the values ​​and the content of porcine reproductive and respiratory syndrome virus in each sample was calculated.

[0144] In the above detection method, the selection of samples to be tested can be diverse, and can be culture fluid, purified fluid, concentrated fluid, etc. in the vaccine production process.

[0145] The result analysis method in step 13) can be: using the OD of each dilution of the antigen standard test well 450nm OD value and negative control well 450nm Use the value as the X-axis and the protein concentration as the Y-axis in the EXCEL program, → "Insert" → "Scatter Plot", select "Scatter Plot with Smooth Line and Data Markers" → "Trend Line" → select "Polynomial" → "Show Formula" and "Show R Square Value". Usually R 2 A value ≥ 0.98 indicates that the standard curve is credible (points with too high or too low OD should be discarded). Each 96-well plate should have a set of standards and a corresponding standard curve should be drawn. According to the polynomial formula, the OD of the sample wells 450nm The value was used to calculate the antigen concentration in the sample.

[0146] The above detection process takes about 1.5 hours, and up to 88 samples can be tested in one experiment.

[0147] Example 6: Sensitivity Detection

[0148] The minimum detection limit test was conducted using three batches of trial-produced porcine reproductive and respiratory syndrome virus antigen detection kits. The prepared antigen standard (antigen content of 4μg / ml) was diluted in a series of 1:20 to 1:1280 times with the sample diluent, and the corresponding antigen concentrations were 200ng / ml, 100ng / ml, 50ng / ml, 25ng / ml, 12.5ng / ml, 6.2ng / ml, and 3.1ng / ml, respectively. The results showed that the minimum detection limit for porcine reproductive and respiratory syndrome concentrated purified antigen was 6.25ng / ml.

[0149] Table 4 Detection of concentrated and purified virus by the PRRSV antigen detection kit

[0150]

[0151] Note: S / N value ≥ 2.1 is considered positive; S / N value < 2.1 is considered negative.

[0152] Example 7, specificity test

[0153] Three batches of porcine reproductive and respiratory syndrome virus antigen detection kits were used to detect Marc-145 cell host protein, porcine circovirus type 2 antigen, foot-and-mouth disease virus type O antigen, foot-and-mouth disease virus type A antigen, and classical swine fever virus antigen, and the results were all negative with a specificity of 100%.

[0154] Example 8: Comparison of the kit and detection method of the present invention with the RT-PCR method

[0155] The porcine reproductive and respiratory syndrome virus antigen detection kit prepared in this study and the RT-PCR detection method were used to simultaneously detect 90 clinical serum samples collected from the clinic, and the compliance rates of the two detection methods were compared. The results showed that the RT-PCR detection method had 16 positive samples and 74 negative samples. The positive samples detected by this kit were 15, and the negative samples were 75. There were 14 samples that were positive in both tests, and 73 samples that were negative, with a total compliance rate of 96.6%.

[0156] Table 5 Comparison between this kit and RT-PCR method

[0157]

Claims

1. An enzyme-linked immunosorbent assay kit for specific quantitative detection of porcine reproductive and respiratory syndrome virus antigen, comprising an enzyme-linked immunosorbent assay plate coated with a monoclonal antibody that can specifically bind to porcine reproductive and respiratory syndrome virus antigen as a capture antibody and an enzyme-labeled antibody.

2. The enzyme-linked immunosorbent assay kit according to claim 1, Features: The enzyme-labeled antibody is an enzyme-labeled antibody prepared by using a monoclonal antibody that is specific to porcine reproductive and respiratory syndrome virus antigen as a detection antibody.

3. The enzyme-linked immunosorbent assay kit according to claim 1 or 2, Features: The capture antibody contains a heavy chain variable region PRRS-Mc1-VH and a light chain variable region PRRS-Mc1-VL; the heavy chain variable region PRRS-Mc1-V H and light chain variable region PRRS-Mc1-V L The PRRS-Mc1-V H and the PRRS-Mc1-V L The complementary regions of the cluster-determining regions are composed of CDR1, CDR2 and CDR3; The PRRS-Mc1-V H The amino acid sequence of CDR1 is shown in amino acids 31 to 35 of SEQ ID No. 1; The PRRS-Mc1-V H The amino acid sequence of CDR2 is shown in amino acids 50 to 66 of SEQ ID No. 1; The PRRS-Mc1-V H The amino acid sequence of CDR3 is shown in amino acids 99 to 110 of SEQ ID No. 1; The PRRS-Mc1-V L The amino acid sequence of CDR1 is shown in amino acids 24 to 34 of SEQ ID No. 2; The PRRS-Mc1-V L The amino acid sequence of CDR2 is shown in amino acids 50 to 56 of SEQ ID No. 2; The PRRS-Mc1-V L The amino acid sequence of CDR3 is shown in amino acids 89 to 97 of SEQ ID No. 2; and / or; The detection antibody contains a heavy chain variable region PRRS-Mc2-VH and a light chain variable region PRRS-Mc2-VL; the heavy chain variable region PRRS-Mc2-VH and the light chain variable region PRRS-Mc2-VL are both composed of a determinant complementary region and a framework region; The complementary regions of the determinant clusters of the PRRS-Mc2-VH and the PRRS-Mc2-VL are both composed of CDR1, CDR2 and CDR3; The PRRS-Mc2-V H The amino acid sequence of CDR1 is shown in amino acids 32 to 35 of SEQ ID No. 3; The PRRS-Mc2-V H The amino acid sequence of CDR2 is shown in amino acids 50 to 66 of SEQ ID No. 3; The PRRS-Mc2-V H The amino acid sequence of CDR3 is shown in amino acids 99 to 105 of SEQ ID No. 3; The PRRS-Mc2-V L The amino acid sequence of CDR1 is shown in amino acids 24 to 33 of SEQ ID No. 4; The PRRS-Mc2-V L The amino acid sequence of CDR2 is shown in amino acids 49 to 55 of SEQ ID No. 4; The PRRS-Mc2-V L The amino acid sequence of CDR3 is shown in amino acids 88 to 96 of SEQ ID No.

4.

4. The enzyme-linked immunosorbent assay kit according to claim 3, Features: The PRRS-Mc1-V H The amino acid sequence of PRRS-Mc1-V is shown in the 1st to 121st positions of SEQ ID No.1 in the sequence list; L The amino acid sequence is shown in positions 1 to 108 of SEQ ID No. 2 in the sequence listing; and / or; said PRRS-Mc2-V H The amino acid sequence of PRRS-Mc2-V is shown in the 1st to 116th positions of SEQ ID No.3 in the sequence list; L The amino acid sequence is shown in positions 1 to 107 of SEQ ID No. 4 in the sequence listing.

5. The ELISA kit according to any one of claims 1 to 4, Features: The method for obtaining the enzyme-linked reaction plate is as follows: the capture antibody is dissolved in 100 μl of a carbonate solution with a pH of 9.6, and then added to a 96-well polystyrene enzyme-linked reaction plate, with 100 ng to 1000 ng of the capture antibody in each well, and placed at 2 to 8° C. for 8 to 12 hours to allow the capture antibody to fully bind to the enzyme-linked reaction plate, and then 300 μl / well of a PBS buffer solution containing 10 mg / ml bovine serum albumin with a pH of 7.4 is added, and the plate is sealed at 37° C. for 2 to 3 hours, and after being dried, the enzyme-linked reaction plate is sealed and stored at 4° C. after drying.

6. The enzyme-linked immunosorbent assay kit according to claim 1, Features: The kit also includes substrate solution A, substrate solution B and stop solution; the substrate solution A is a citric acid phosphate buffer solution containing 0.6 mg / ml hydrogen peroxide urea, and the substrate solution B is a 0.2 mg / ml tetramethylbenzidine solution, and the two are mixed in a ratio of 1:1 when used; the stop solution is a 2 mol / L sulfuric acid solution.

7. The kit according to claim 1, Features: The kit also includes a sample diluent and a 20-fold concentrated washing solution; the sample diluent is a 0.01M phosphate buffer containing 5mg / ml casein and a pH value of 7.4; the 20-fold concentrated washing solution is a 0.01M phosphate buffer containing 0.8% to 1.2% (ml / ml) Tween-20 and a pH value of 7.

4.

8. A monoclonal antibody that can specifically bind to a porcine reproductive and respiratory syndrome virus antigen, which is any one of the following monoclonal antibodies: 1) Contains the heavy chain variable region PRRS-Mc1-V H and chain variable region PRRS-Mc1-V L ; The heavy chain variable region PRRS-Mc1-V H and light chain variable region PRRS-Mc1-V L They are all composed of cluster-determining complementarity regions and framework regions; The PRRS-Mc1-V H and the PRRS-Mc1-V L The complementary regions of the cluster-determining regions are composed of CDR1, CDR2 and CDR3; The PRRS-Mc1-V H and the PRRS-Mc1-V L The complementary regions of the cluster-determining regions are composed of CDR1, CDR2 and CDR3; The PRRS-Mc1-V H The amino acid sequence of CDR1 is shown in amino acids 31 to 35 of SEQ ID No. 1; The PRRS-Mc1-V H The amino acid sequence of CDR2 is shown in amino acids 50 to 66 of SEQ ID No. 1; The PRRS-Mc1-V H The amino acid sequence of CDR3 is shown in amino acids 99 to 110 of SEQ ID No. 1; The PRRS-Mc1-V L The amino acid sequence of CDR1 is shown in amino acids 24 to 34 of SEQ ID No. 2; The PRRS-Mc1-V L The amino acid sequence of CDR2 is shown in amino acids 50 to 56 of SEQ ID No. 2; The PRRS-Mc1-V L The amino acid sequence of CDR3 is shown in amino acids 89 to 97 of SEQ ID No. 2; 2) Containing the heavy chain variable region PRRS-Mc2-V H and chain variable region PRRS-Mc2-V L ; The heavy chain variable region PRRS-Mc2-V H and light chain variable region PRRS-Mc2-V L They are all composed of cluster-determining complementarity regions and framework regions; The PRRS-Mc2-V H and the PRRS-Mc2-V L The complementary regions of the cluster-determining regions are composed of CDR1, CDR2 and CDR3; The PRRS-Mc2-V H and the PRRS-Mc2-V L The complementary regions of the cluster-determining regions are composed of CDR1, CDR2 and CDR3; The PRRS-Mc2-V H The amino acid sequence of CDR1 is shown in amino acids 32 to 35 of SEQ ID No. 3; The PRRS-Mc2-V H The amino acid sequence of CDR2 is shown in amino acids 50 to 66 of SEQ ID No. 3; The PRRS-Mc2-V H The amino acid sequence of CDR3 is shown in amino acids 99 to 105 of SEQ ID No. 3; The PRRS-Mc2-V L The amino acid sequence of CDR1 is shown in amino acids 24 to 33 of SEQ ID No. 4; The PRRS-Mc2-V L The amino acid sequence of CDR2 is shown in amino acids 49 to 55 of SEQ ID No. 4; The PRRS-Mc2-V L The amino acid sequence of CDR3 is shown in amino acids 88 to 96 of SEQ ID No. 4; 3) Containing the heavy chain variable region PRRS-Mc1-V H and light chain variable region PRRS-Mc1-V L ; The PRRS-Mc1-V H The amino acid sequence of PRRS-Mc1-V L The amino acid sequence is shown in positions 1 to 108 of SEQ ID No. 2 in the sequence listing; 4) Containing the heavy chain variable region PRRS-Mc2-V H and light chain variable region PRRS-Mc2-V L ; The PRRS-Mc2-V H The amino acid sequence of PRRS-Mc2-V is shown in the 1st to 116th positions of SEQ ID No.3 in the sequence list; L The amino acid sequence is shown in positions 1 to 107 of SEQ ID No. 4 in the sequence listing.

9. Use of the enzyme-linked immunosorbent assay kit according to claims 1-8 in the specific quantitative detection of porcine reproductive and respiratory syndrome virus antigens, preferably, the sample to be tested is a culture fluid, purified fluid, or concentrated fluid in the vaccine production process.

10. Use of the monoclonal antibody according to claim 8 in the preparation of a kit for detecting porcine reproductive and respiratory syndrome virus antigens.